SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has announced that 28,500 share options from its Post-IPO Option Plan were recently exercised, resulting in a new total of 630,265,632 shares issued. Additionally, there are now 66,518,432 share options in issue, divided among various plans, with a significant portion already vested. This update comes amidst the process of a proposed privatization scheme by Silver Pegasus Investment Limited.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.